SCHEMBL29849995

SCHEMBL29849995

NC1CN(c2cc(Br)ccn2)C1

nearest known ligand 0.44

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ HRH4 Q9H3N8 6/20 0.44
▸ ACACB O00763 1/20 0.43
▸ HRH3 Q9Y5N1 5/20 0.40
▸ KDM4E B2RXH2 1/20 0.38
▸ ALDH1A1 P00352 1/20 0.38
▸ SMN1; SMN2 Q16637 1/20 0.38
▸ WNT1 P04628 3/20 0.35
▸ DYRK1A Q13627 3/20 0.35
▸ GSK3B P49841 2/20 0.35
▸ CLK2 P49760 2/20 0.34
▸ CLK3 P49761 2/20 0.34
▸ KARS1 Q15046 1/20 0.34
▸ ROCK1 Q13464 1/20 0.33
▸ MAP3K14 Q99558 1/20 0.33
▸ PAK4 O96013 1/20 0.33
▸ PAK1 Q13153 1/20 0.33
▸ DPP4 P27487 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21812486 0.82 ACACB (0.45) HRH4ACACBKDM4EALDH1A1SMN1; SMN2
SCHEMBL24454257 0.79 GRIN2D (0.49) HRH4HRH3KDM4EALDH1A1SMN1; SMN2
SCHEMBL30729441 0.78 LRRK2 (0.46) ACACBKDM4EALDH1A1WNT1DYRK1A
SCHEMBL22290812 0.78 LRRK2 (0.46) ACACBKDM4EALDH1A1WNT1DYRK1A
SCHEMBL29889142 0.78 LRRK2 (0.46) ACACBKDM4EALDH1A1WNT1DYRK1A
SCHEMBL23860614 0.78 NMT1 (0.46) ACACB
SCHEMBL22290811 0.78 LRRK2 (0.46) ACACBKDM4EALDH1A1WNT1DYRK1A
SCHEMBL21812444 0.76 HRH4 (0.47) HRH4ACACBKDM4EALDH1A1SMN1; SMN2
SCHEMBL789776 0.76 HRH4 (0.51) HRH4ACACBKDM4EALDH1A1SMN1; SMN2
SCHEMBL30476654 0.76 HRH4 (0.51) HRH4ACACBKDM4EALDH1A1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022173849-A1 (HETERO)ARYLAMINO-CYCLOHEXYL-SULFONYL DERIVATIVES AS CCR6 INHIBITORS QILU REGOR THERAPEUTICS INC. (CN) 2022-08-18 — — WO disclosed
Send feedback